The SWAN study of 3292 pre- and postmenopausal women found that over a five-year observation period, higher depression scores were related to higher levels of fibrinogen and plasminogen activation inhibitor type one (PAI-1) but not CRP [11]. The gene discussed is CRP; the disease is depressive symptom measurement.